OPEN LABEL [resa]
randomized [resa]
Study [mnob]
Efficacy [qlco]
atorvastatin [orch, phsu]
Usual [qlco]
Care [acty]
Reducing [qlco]
Refractory [ftcn]
Hypercholesterolaemia [dsyn]
High Risk [qlco]
Patients [podg]
Target [ftcn]
Objective [inpr]
OPEN LABEL [resa]
randomized [resa]
Parallel Study [resa]
Arm [blor]
Efficacy [qlco]
Safety [hcpp]
atorvastatin [orch, phsu]
mg/d [qnco]
Usual [qlco]
Care [acty]
High Risk [qlco]
Patients [podg]
Refractory [ftcn]
Current [tmco]
Lipid-lowering therapy [topp]
Fibrates [orch, phsu]
Statins [orch, phsu]
atorvastatin [orch, phsu]
Excluded [idcn]
resins [bodm]
Methods [inpr]
Seven [qnco]
Patients [podg]
Men [popg]
Women [popg]
Aged [orga]
Persistent [tmco]
Hypercholesterolaemia [dsyn]
Low Density Lipoprotein Cholesterol [bacs, strd]
Inclusion [qlco]
mg dl [qnco]
Assigned [ftcn]
Run-in Period [tmco]
Continued [idcn]
Lipid-lowering therapy [topp]
Patients [podg]
Personal History [fndg]
coronary heart disease [dsyn]
weeks [tmco]
treatment [ftcn]
Patients [podg]
Recommended [idcn]
Target [ftcn]
atorvastatin [orch, phsu]
Group [idcn]
Group A [clas]
Compared [acty]
Usual [qlco]
Care [acty]
Group [idcn]
Group [idcn]
P NOS [aapp, imft]
Usual [qlco]
Care [acty]
included [ftcn]
Doses [qnco]
Switch [mnob]
Drugs [phsu]
Combine [mnob]
Drugs [phsu]
prescribing [hlca]
aggressive [mobd]
Dietary [food]
Treatments [topp]
Drugs [phsu]
Group [idcn]
Bezafibrate [orch, phsu]
ciprofibrate [orch, phsu]
Fenofibrate [orch, phsu]
Gemfibrosil [lipd, phsu]
fluvastatin [orch, phsu]
Pravastatin [orch, phsu]
Simvastatin [orch, phsu]
cerivastatin [orch, phsu]
Decreased [qnco]
mg dl [qnco]
mg dl [qnco]
Group A [clas]
mg dl [qnco]
mg dl [qnco]
Group [idcn]
P NOS [aapp, imft]
4 Weeks [tmco]
treatment [ftcn]
Target [ftcn]
Values [qlco]
Patients [podg]
Group A [clas]
Low dose [qnco]
mg/d [qnco]
Group [idcn]
P NOS [aapp, imft]
frequency [qnco]
Drug [phsu]
adverse events [fndg]
Withdrawal [acty]
atorvastatin [orch, phsu]
Conclusions [idcn]
Study [mnob]
High Risk [qlco]
Patients [podg]
Hypercholesterolaemia [dsyn]
Refractory [ftcn]
Lipid [lipd]
lowering [spco]
atorvastatin [orch, phsu]
therapy [ftcn]
Target [ftcn]
short period [fndg]
adverse events [fndg]
Recommended [idcn]
Target [ftcn]
Best [qlco]
Approach [spco]
Treatment Efficacy [qlco]
